We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+14.87%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$6.83B
AUM Growth
+$1.02B
Cap. Flow
+$234M
Cap. Flow %
3.43%
Top 10 Hldgs %
21.97%
Holding
591
New
39
Increased
207
Reduced
104
Closed
35

Top Sells

Rank Stock Value
1
HES
Hess
HES
+$36.7M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$11.3M
3
LGIH icon
LGI Homes
LGIH
+$10.4M
4
CMI icon
Cummins
CMI
+$9.78M
5
MRK icon
Merck
MRK
+$9.77M

Sector Composition

Rank Sector Weight
1 Technology 34.29%
2 Healthcare 17.66%
3 Consumer Discretionary 9.75%
4 Industrials 9.46%
5 Financials 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNM icon
451
Unum
UNM
$14.1B
$344K 0.01%
7,600
VEEV icon
452
Veeva Systems
VEEV
$34.7B
$344K 0.01%
1,800
RPM icon
453
RPM International
RPM
$14.9B
$336K ﹤0.01%
3,000
PCRX icon
454
Pacira BioSciences
PCRX
$991M
$329K ﹤0.01%
9,800
QTTB icon
455
Q32 Bio
QTTB
$491M
$328K ﹤0.01%
30,000
LGND icon
456
Ligand Pharmaceuticals
LGND
$6.06B
$309K ﹤0.01%
4,300
ARE icon
457
Alexandria Real Estate Equities
ARE
$8.62B
$304K ﹤0.01%
+2,400
New +$258K
INBX
458
DELISTED
Inhibrx, Inc. Common Stock
INBX
$304K ﹤0.01%
8,700
CRVL icon
459
CorVel
CRVL
$3.19B
$301K ﹤0.01%
3,600
VIR icon
460
Vir Biotechnology
VIR
$1.54B
$296K ﹤0.01%
28,800
AROC icon
461
Archrock
AROC
$5.95B
$294K ﹤0.01%
+19,000
New +$264K
IOVA icon
462
Iovance Biotherapeutics
IOVA
$1.94B
$292K ﹤0.01%
34,000
GRFS
463
Grifois
GRFS
$5.4B
$285K ﹤0.01%
27,056
PICK icon
464
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.34B
$283K ﹤0.01%
6,850
CHGG icon
465
Chegg
CHGG
$115M
$272K ﹤0.01%
23,808
PVH icon
466
PVH
PVH
$4.01B
$271K ﹤0.01%
2,202
RLAY icon
467
Relay Therapeutics
RLAY
$4.29B
$262K ﹤0.01%
23,100
BCYC
468
Bicycle Therapeutics
BCYC
$278M
$262K ﹤0.01%
14,000
RDN icon
469
Radian Group
RDN
$5.21B
$255K ﹤0.01%
8,800
BNY
470
Bank of New York Mellon
BNY
$108B
$253K ﹤0.01%
4,841
MORF
471
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$252K ﹤0.01%
8,500
BCRX icon
472
BioCryst Pharmaceuticals
BCRX
$2.31B
$244K ﹤0.01%
40,000
OTIS icon
473
Otis Worldwide
OTIS
$27.8B
$242K ﹤0.01%
2,701
-50,160
-95% -$4.17M
RGNX icon
474
Regenxbio
RGNX
$672M
$241K ﹤0.01%
13,000
CINF icon
475
Cincinnati Financial
CINF
$27.3B
$238K ﹤0.01%
2,300

Similar funds

Erste Asset Management's Q4 2023 Portfolio in Review

As of Q4 2023, Erste Asset Management held 591 positions worth $6.83B, up 18% from $5.81B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Erste Asset Management deployed $234M of net new capital in Q4 2023, opening 39 new positions and adding to 207 existing holdings. Its largest new stake was AutoZone: 3,190 shares worth $8.25M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was LGI Homes, an estimated $10.4M trimmed.

  • Erste Asset Management's largest Q4 2023 buy was AutoZone: 3,190 shares worth $8.25M.
  • Erste Asset Management added most to Intel in Q4 2023, an estimated $16M increase.
  • Erste Asset Management's biggest Q4 2023 reduction was LGI Homes, cutting an estimated $10.4M.
  • Erste Asset Management fully exited Hess in Q4 2023, selling an estimated $36.7M.
  • Erste Asset Management's ten largest holdings make up 22% of its $6.83B portfolio in Q4 2023.
  • Erste Asset Management opened 39 new positions and closed 35 in Q4 2023.
  • Erste Asset Management's portfolio value rose 18% quarter-over-quarter to $6.83B.

Based on Erste Asset Management's 13F filing for Q4 2023, filed 26 Nov 2024.